Notice2024-16492
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 26, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled "Division of Diabetes Translation Programmatic & Participant User Experience Data Collection" (DDTDC). This Generic information collection, will enable CDC's Division of Diabetes Translation (DDT) to collect data required in a timely manner to support the development, refinement, and improvement of DDT's education, training, technical assistance (TA), and communication/marketing activities.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 144 (Friday, July 26, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 144 (Friday, July 26, 2024)]
[Notices]
[Pages 60636-60638]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-16492]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-24HQ; Docket No. CDC-2024-00057]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled ``Division of Diabetes Translation Programmatic & Participant
User Experience Data Collection'' (DDTDC). This Generic information
collection, will enable CDC's Division of Diabetes Translation (DDT) to
collect data required in a timely manner to support the development,
refinement, and improvement of DDT's education, training, technical
assistance (TA), and communication/marketing activities.
DATES: CDC must receive written comments on or before September 24,
2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0057 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to <a href="http://www.regulations.gov">www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: <a href="/cdn-cgi/l/email-protection#127d7f70527176713c757d64"><span class="__cf_email__" data-cfemail="8be4e6e9cbe8efe8a5ece4fd">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of the existing collection
of information, and each reinstatement of previously approved
information collection before submitting the collection to the OMB for
approval. To comply with this requirement, we are publishing this
notice of a proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information,
[[Page 60637]]
including the validity of the methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of collecting information on those to
respond, including using appropriate automated, electronic, mechanical,
or other technological collection techniques or other forms of
information technology, e.g., permitting electronic responses; and
5. Assess information collection costs.
Proposed Project
Division of Diabetes Translation Programmatic & Participant User
Experience Data Collection (DDTDC)--New--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Division of Diabetes Translation (DDT) plays a crucial role in
helping prevent Type 2 diabetes, reducing diabetes complications and
disability, and reducing diabetes-related disparities across the United
States. DDT accomplishes this by providing education, training,
technical assistance (TA), and engaging in communication/marketing
activities for various key audiences. These customers include national,
state, and local partners, grantees, providers (e.g., lifestyle
coaches, diabetes educators, healthcare providers, health/medical and
community-based organizations), people with prediabetes, diabetes and
their family, friends, and caregivers, and other consumers of DDT
products and programs.
For DDT to be able to efficiently and effectively do this work and
fulfill its mission, it needs to be able to collect information and
feedback from intended audiences in a timely manner and with enough
frequency to ensure DDT can deliver clear, effective, efficient, and
appropriate customer service. This includes, for instance, collecting
data on key audiences' needs, and on the reach, uptake, use, customer
experience and satisfaction with DDT's services, products, and related
programs, including its education, training, TA and communications
services and products. However, in the interest of timely provision of
services, DDT often forgoes the important step of getting input from
its key audiences on the clarity, efficiency, effectiveness, and
appropriateness of the services and resources it develops and provides
for them. Skipping this information collection step, or doing so with
less frequency, avoids the delay involved in the standard OMB review
process increases the risk of DDT wasting both time and money
developing and providing education, training, TA, and communication/
marketing that will not achieve the intended objectives and will be
unclear, irrelevant, or not fully meet the needs of DDT's audiences. It
can also have other unintended consequences, such as jeopardizing the
credibility of Federal health officials.
The Division of Diabetes Translation Programmatic & Participant
User Experience Data Collection (DDTDC) will enable DDT to collect the
information they require in a timely manner to:
<bullet> Provide clear, effective, efficient, appropriate, and
timely education, communication, training, and technical assistance to
key audiences and other interested groups, including consumer audiences
(e.g., people with prediabetes, diabetes, and their family, friends,
and caregivers), providers (e.g., lifestyle coaches, diabetes care and
education specialists, healthcare and other providers, health/medical
and community-based organizations); and partners (national, state, and
local partners).
<bullet> Ensure quality and prevent duplication in the development
and dissemination of prevention and health information and program
activities by DDT to consumers, providers, and state and local
partners.
<bullet> Conduct exploratory/formative assessments to inform DDT's
development of education, communication/marketing, training, and
programmatic materials, tools, and resources to support and improve the
prevention and management of diabetes. For example, identifying key
audiences' knowledge, attitudes, behaviors, motivators, and information
needs.
<bullet> Assess the impact of programs, messages, educational and
training materials among recipients and determine to what extent they
meet relevant service-related DDT objectives and goals.
The following are examples of the areas of focus that the data
collection activities under this generic information collection
mechanism may include:
<bullet> Reach, uptake, use, customer experience, and satisfaction
with the CDC-recognized lifestyle change programs for Type 2 diabetes
prevention, as well as related outcomes (e.g., participant retention
and recruitment rates).
<bullet> Satisfaction with CDC-recognized lifestyle change programs
toolkits, such as the Personal Success Tool and Champion toolkits.
<bullet> Reach, uptake, use, customer experience, and satisfaction
with diabetes education, type 2 prevention, and diabetes management
innovations (such as the Diabetes Self-Management Education and Support
services promotion initiative) and related short-term effects on
knowledge, awareness, practices (such as information seeking), and
outcomes (such as enrollment of people with diabetes or prediabetes).
<bullet> Reach, uptake, satisfaction, customer experience, and
short-term outcomes of CDC's training and technical assistance
resources (such as a webinar or online toolkit).
<bullet> Needs assessments for customer experience with,
utilization of, and short-term outcomes of technical assistance and
trainings for diabetes prevention and management.
<bullet> Understandability, ease of use, and appropriateness of
diabetes education messages, toolkits, programs, and marketing
materials.
<bullet> Exploratory assessments of knowledge, attitudes,
behaviors, beliefs, barriers, and facilitators to uptake and use of
lifestyle change programs for diabetes type 2 prevention and diabetes
management services and related innovations, resources, tools, and
materials.
Data collection methods proposed include, but are not limited to
in-depth individual interviews, cognitive interviews, intercept
interviews, group-based discussions (including focus groups and dyads/
triads), surveys or questionnaires, knowledge assessments,
observational assessments, and implementation and utilization data
reporting. Respondents would include key audiences and stakeholders of
CDC's work, including representatives of state and local DDT-funded
organizations; national, state, and local DDT partners (not CDC-
funded); providers of type 2 diabetes prevention and diabetes
management programs and services, including lifestyle coaches, diabetes
care and educations specialists, healthcare and other providers; heath/
medical and community-based organizations implementing programs and
services related to type 2 diabetes prevention and diabetes management;
people with--and at risk for--diabetes or with prediabetes; family,
friends, and caregivers of people with--and at risk for--diabetes or
with prediabetes.
As the methods for data collection and audiences may vary with each
request submitted under this proposed generic clearance, for each data
collection request unique instruments (e.g., surveys, interview guides)
will be developed to address the specific topics that information will
be collected on.
[[Page 60638]]
Questions to be asked may focus, for example, on collecting data on the
audiences' needs and on the reach, uptake, use, customer experience and
satisfaction with DDT's services, products, and programs. Such
information will enable DDT to identify ways to improve its services,
products, and programs to better meet its audiences' needs and achieve
its mission of supporting the prevention of diabetes and reducing
diabetes-related complications and disparities across the United
States.
The estimated annualized hourly burden anticipated for all data
collection methods would total 2,000 hours and include eight to ten
data collection activities over the course of a year. There is no cost
to the respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondents Data collection Number of responses per Average burden Total burden
methods respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
Representatives of state and Interviews; 4,000 1 30/60 2,000
local DDT-funded Surveys or
organizations; National, Questionnaires;
State, and Local DDT Knowledge
partners; Providers of type 2 Assessments;
Diabetes Prevention and Motivation
Diabetes Management Programs Assessments,
and Services; People, family, Observational
friends, and caregivers of Assessments;
people with--and at risk for-- Implementation
Diabetes or with Prediabetes. and Utilization
Data Reporting.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 2,000
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-16492 Filed 7-25-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 26, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.